Things categorized as 'License/Partnership'
AVEO and Biogen Team Up
AVEO and Biogen announced a strategic collaboration for the development and commercialization of AVEO’s novel discovery-stage ErbB3-targeted antibodies for the potential treatment of cancer and ...
Symphogen and Origen Collaborate Will Develop Transgenic Chickens Capable Of…..
[caption id="" align="alignleft" width="200" caption="From hddod onFlickr"][/caption] Sounds ominous, no? Symphogen and Origen announced a collaboration to develop a transgenic chicken capable of producing human antibodies ...
Proteon Therapeutics Has A Big Day
Proteon Therapeutics announced it has successfully completed a $38 million Series B equity financing, started a Phase 1/2 clinical trial with its lead product, PRT-201, ...
Lilly Taps NeuroSearch For Preclinical Discovery Deal
Just a week after NeuroSearch failed a phase II pain trial (ABT-894), they've inked a collaboration which will focus on new CNS ...
Orexo Licenses Development for OX17 to Mystery Suitor
Orexo has signed an exclusive development agreement with "a large healthcare company", providing for joint development within Orexo’s OX17 program for gastroesophageal reflux disease (GERD), ...
Idenix Take $34M Upfront From GSK For IDX899
Idenix and GlaxoSmithKline announced the execution of a license agreement granting GSK exclusive worldwide rights to IDX899. Terms -------------------------------- Upfront: $34M ($17M in cash; $17M equity stake ...
S*Bio and Tragara Pharmaceuticals Enter Alliance For Multi-kinase Inhibitor
S*BIO and Tragara today announced that S*BIO has granted a worldwide exclusive license to Tragara to develop and commercialize its novel multi-kinase inhibitor SB1317. Under the ...
Peptimmune Lands Licensing Deal With Novartis for PI-2301
Peptimmune announced today that it has granted Novartis an exclusive option to obtain exclusive worldwide rights to develop and commercialize PI-2301 for multiple sclerosis. The ...
Merck Serono and Apitope Collaborate on MS Drug
Merck Serono and Apitope entered a research, development and commercialization agreement for ATX-MS-1467. Under this agreement, Apitope has granted exclusive worldwide rights to Merck Serono ...
Bristol-Myers Squibb Enters Hep C Race With Help From ZymoGenetics
Bristol-Myers Squibb has decided to jump into the hotter by the second race for hepatitis C therapies. BMS and ZymoGenetics have entered a global collaboration ...
Alnylam and Cubist to Codevelop Respiratory Syncytial Virus (RSV) Infection Therapy
Cubist and Alnylam have formed a strategic collaboration to develop and commercialize Alnylam’s ALN-RSV program. The RSV-specific RNAi therapeutic program ...
BioMarin Enters Pact with La Jolla For Lupus Candidate
BioMarin Pharmaceutical and La Jolla Pharmaceutical Company announced that they have entered into an agreement to develop and commercialize Riquent®, ...
GlaxoSmithKline and Dynavax announce worldwide strategic alliance
GlaxoSmithKline and Dynavax announced a worldwide strategic alliance to discover, develop and commercialise novel inhibitors of endosomal Toll-like Receptors (TLRs) for the treatment of immuno-inflammatory ...
Ascent Therapeutics Enters $200M Pact With Novartis For Pepducins
Ascent Therapeutics announced that it has entered into a licensing option agreement through the Novartis Option Fund. Ascent will discover and develop Pepducin drug candidates ...